Pfizer's Depo-Provera Settlement: What Women With Meningioma Need to Know About the June 2026 Agreement

Pfizer has settled litigation involving its Depo-Provera contraceptive injection and claims that the drug increased the risk of meningioma (a type of brain tumor) in women users. The settlement became effective in June 2026 and establishes a framework for eligible women with meningioma diagnoses to seek compensation and obtain information about their legal rights and the underlying health risks. The specific settlement amount and claim procedures are outlined for affected plaintiffs.

This is a curated brief from the PlaintiffWire news desk. Read the original report at JD Supra.